REG - Biofrontera AG - Director/PDMR Shareholding <Origin Href="QuoteRef">B8FGn.DE</Origin>

Biofrontera AGAnnouncement

29/10/2014 10:15

RNS Number : 1313R
Biofrontera AG
08 September 2014
Biofrontera AG
("Biofrontera" or the "Company")
Director Dealing
Biofrontera AG (AIM:B8F), the European biopharmaceutical company, announces that on 4 September 2014 Thomas Schaffer, the Chief Financial Officer of the Company, purchased a further 1,500 ordinary shares of no par value in the capital of the Company ("Ordinary Shares") at a price of EUR 2.347 per Ordinary Share. Subsequent to this transaction Mr Schaffer has a beneficial interest in 11,588 Ordinary Shares representing 0.05% of the issued ordinary share capital of the Company.
For further information, please contact:
Biofrontera AG
Prof. Hermann Lbbert, Chief Executive Officer
Thomas Schaffer , Chief Financial Officer
Tel:+ 49 (0) 214 - 87632 - 22
finnCap (Nomad and Broker)
Geoff Nash / Christopher Raggett (Corporate Finance)
Tel: 020 7220 0500
Steven Norcross(Corporate Broking)
Investor Relations
Seton Services
Toni Vallen
Tel: 020 7603 6797
Financial PR
Gable Communications
John Bick
Tel: 020 7193 7463

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSLPMRTMBBMBLI